Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose
Joseph V. Pergolizzi(Nema Research (United States)), Robert B. Raffa(United Therapeutics (United States)), Lynn R. Webster(Adherent Technologies (United States)), Jo Ann LeQuang(ACI Worldwide (United States)), Eugene Vortsman(Northwell Health)
Cited by 51
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain
|Journal of Pain and Symptom Management|2006|304